Michael Ben Colicchio, RPAC

Michael Colicchio practices at Noyes Memorial Hospital in Dansville, New York, part of University of Rochester Medical Center.

Michael Colicchio's NPI, 1174610950, was assigned on October 5, 2006. Michael Colicchio holds New York license 4538580.

Michael Colicchio's primary practice is Noyes Memorial Hospital, at 111 Clara Barton Street, Dansville, NY 14437 in Livingston County. The practice phone is (585) 335-6001.

Michael Colicchio's primary practice is Noyes Memorial Hospital in Dansville, New York, part of University of Rochester Medical Center. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Michael Colicchio to 3 more medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Colicchio practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Michael Colicchio's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Michael Colicchio is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Michael Colicchio is licensed in New York.

Dmand AI lists gastroenteritis among the conditions Michael Colicchio treats.

CMS data shows 84 Medicare services from Michael Colicchio across 2 procedure codes in 2024, all of them office visits, for 82 Medicare patients. Medicare paid $4,673 for them.

CMS counts 82 Medicare patients who saw Michael Colicchio in 2024. The largest group is 65 to 74, with 29 patients. 71% of them have high cholesterol, and 67% have high blood pressure. 37% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Colicchio's median patient age at 71, with 60% women.

In 2024, Michael Colicchio wrote 2,666 Medicare Part D claims for 622 patients. 81% of them were for generic drugs. CMS names the drug for 2,454 of them, across 40 drugs with 11 or more claims each, at $570,681 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Michael Colicchio for performance year 2024, reported as part of a group.

CMS Open Payments shows 1 general payment to Michael Colicchio from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $109.